Feb 2, 2021 06:32PM moth wrote:
imaging is frequently not as accurate as the actual surgical excision so size changes post op are normal. Also, imaging cannot see all cancer in lymph nodes - the technology just isn't there. If it's small or the structure of the lymph node obscures it, it will be missed. That's why they do at least sentinel node biopsy at surgery....
80% necrotic is a good sign - sounds like it was dying from within.
re the xeloda, I'm looking at the NCCN guidelines (version 5.2020) and it does say for triple neg with positive node or residual disease "consider capecitabine 6-8 cycles" but that it should be after radiation.
So perhaps the MO just hasn't got to that point yet? I would definitely ask about what the MO is planning.
Don't let it get you down. Plenty of triple negs do very well, even with lymph invasion. Just keep plugging through the treatment.
Initial dx at 50. Seriously?? “Sometimes the future changes quickly and completely and we’re left with only the choice of what to do next." blog: Never Tell Me the OddsDx 12/2017, IDC, Left, 1cm, Stage IA, Grade 3, 0/5 nodes, ER-/PR-, HER2- (IHC) Surgery 12/12/2017 Lumpectomy: Left; Lymph node removal: Sentinel Chemotherapy 2/14/2018 AC + T (Taxol) Radiation Therapy 8/13/2018 Whole-breast: Breast Dx 2/2020, IDC, Stage IV, metastasized to liver/lungs, Grade 3, ER-/PR-, HER2- Chemotherapy 3/18/2020 Taxol (paclitaxel) Immunotherapy 3/19/2020 Tecentriq (atezolizumab) Chemotherapy 11/26/2020 Abraxane (albumin-bound or nab-paclitaxel) Dx 12/9/2020, IDC, Right, Stage IV, metastasized to lungs, Grade 3, ER+/PR-, HER2- (IHC) Radiation Therapy 12/9/2020 External Hormonal Therapy 12/16/2020 Femara (letrozole) Dx 1/28/2021, IDC, Left, Stage IV, metastasized to bone Radiation Therapy 3/3/2021 External: Bone